BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20817687)

  • 1. Exploring the role of economics in prioritization in public health: what do stakeholders think?
    Phillips CJ; Fordham R; Marsh K; Bertranou E; Davies S; Hale J; Kingsley M; Parke S; Porteous C; Rance J; Warm D
    Eur J Public Health; 2011 Oct; 21(5):578-84. PubMed ID: 20817687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A census of economic evaluations in health promotion.
    Rush B; Shiell A; Hawe P
    Health Educ Res; 2004 Dec; 19(6):707-19. PubMed ID: 15199000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics in public health.
    Ammerman AS; Farrelly MA; Cavallo DN; Ickes SB; Hoerger TJ
    Am J Prev Med; 2009 Mar; 36(3):273-5. PubMed ID: 19215853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing policy solutions for a more active nation: Integrating economic and public health perspectives.
    Bleich SN; Sturm R
    Prev Med; 2009 Oct; 49(4):306-8. PubMed ID: 19616575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research evaluation and policy in dental public health.
    Lipton JA
    Curr Opin Dent; 1991 Jun; 1(3):329-36. PubMed ID: 1839360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing costs and potential returns of evidence-based programs for seniors.
    Miller TR; Dickerson JB; Smith ML; Ory MG
    Eval Health Prof; 2011 Jun; 34(2):201-25. PubMed ID: 21196430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introduction to methods of economic modelling: a primer for orthopaedic surgeons and traumatologists].
    Vavken P; Dorotka R
    Z Orthop Unfall; 2009; 147(4):419-23. PubMed ID: 19771671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health services and health economics].
    Cilingiroglu N
    Nufusbil Derg; 1988; 10():45-50. PubMed ID: 12342133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exercise on the feasibility of carrying out secondary economic analyses.
    Jefferson T; Mugford M; Gray A; Demicheli V
    Health Econ; 1996; 5(2):155-65. PubMed ID: 8733107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-benefit analysis in occupational health: a comparison of intervention scenarios for occupational asthma and rhinitis among bakery workers.
    Meijster T; van Duuren-Stuurman B; Heederik D; Houba R; Koningsveld E; Warren N; Tielemans E
    Occup Environ Med; 2011 Oct; 68(10):739-45. PubMed ID: 21632520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].
    Triomphe A
    Diabete Metab; 1993 Dec; 19(5 Suppl):473-6. PubMed ID: 8206181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis for priority setting in health: penny-wise but pound-foolish.
    Baltussen R; Brouwer W; Niessen L
    Int J Technol Assess Health Care; 2005; 21(4):532-4. PubMed ID: 16262980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.